We are live on ! Find out more
PCA

Private Capital Advisors Portfolio holdings

AUM $1.14B
1-Year Est. Return 48.66%
This Fund
S&P 500
This Quarter Est. Return
+4.78%
1 Year Est. Return
+48.66%
3 Year Est. Return
+137.63%
5 Year Est. Return
+227.94%
10 Year Est. Return
+772.14%
AUM
$232M
AUM Growth
-$7.38M
Cap. Flow
-$16.7M
Cap. Flow %
-7.19%
Top 10 Hldgs %
29.39%
Holding
116
New
2
Increased
6
Reduced
34
Closed
9

Top Buys

Rank Stock Value
1
TVRD
Tvardi Therapeutics
TVRD
+$3.76M
2
RCKT icon
Rocket Pharmaceuticals
RCKT
+$523K
3
PVH icon
PVH
PVH
+$327K
4
CMCSA icon
Comcast
CMCSA
+$58.7K
5
NFLX icon
Netflix
NFLX
+$11.4K

Top Sells

Rank Stock Value
1
AGTC
Applied Genetic Technologies Corporation
AGTC
+$4.54M
2
QCOM icon
Qualcomm
QCOM
+$2.2M
3
IONS icon
Ionis Pharmaceuticals
IONS
+$1.71M
4
KKR icon
KKR & Co
KKR
+$1.63M
5
MGNX icon
MacroGenics
MGNX
+$1.32M

Sector Composition

Rank Sector Weight
1 Healthcare 29.01%
2 Communication Services 22.71%
3 Energy 13.38%
4 Industrials 12.54%
5 Technology 5.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VZ icon
51
Verizon
VZ
$208B
$1.46M 0.63%
31,600
– –
KKR icon
52
KKR & Co
KKR
$97.6B
$1.23M 0.53%
78,800
-95,050
-55% -$1.63M
OMC icon
53
Omnicom Group
OMC
$24.2B
$1.21M 0.52%
16,000
– –
FWONA icon
54
Liberty Media Series A
FWONA
$23.4B
$1.2M 0.52%
45,599
– –
RTX icon
55
RTX Corp
RTX
$285B
$1.17M 0.51%
19,418
– –
WRK
56
DELISTED
WestRock Company
WRK
$1.14M 0.49%
27,623
– –
GILD icon
57
Gilead Sciences
GILD
$181B
$1.13M 0.49%
11,194
– –
JNJ icon
58
Johnson & Johnson
JNJ
$646B
$1.11M 0.48%
10,855
– –
LBRDK
59
DELISTED
Liberty Broadband Class C
LBRDK
$990K 0.43%
19,082
– –
CHTR icon
60
Charter Communications
CHTR
$18.3B
$952K 0.41%
5,200
– –
CVS icon
61
CVS Health
CVS
$119B
$826K 0.36%
8,450
– –
MSFT icon
62
Microsoft
MSFT
$3.81T
$825K 0.36%
14,875
– –
KO icon
63
Coca-Cola
KO
$386B
$773K 0.33%
18,000
– –
QQQ icon
64
Invesco QQQ Trust
QQQ
$489B
$748K 0.32%
6,690
– –
BALL icon
65
Ball Corp
BALL
$16.9B
$737K 0.32%
20,260
– –
UAN icon
66
CVR Partners
UAN
$1.32B
$701K 0.3%
8,756
-35
-0.4% -$3.1K
AEP icon
67
American Electric Power
AEP
$66.6B
$629K 0.27%
10,790
– –
NGLS
68
DELISTED
TARGA RESOURCES PARTNERS LP COM UTS REPTG LTD PARTERSHIP INT
NGLS
$618K 0.27%
37,395
-19,602
-34% -$485K
INTU icon
69
Intuit
INTU
$97.9B
$593K 0.26%
6,150
– –
EQT icon
70
EQT Corp
EQT
$34.1B
$589K 0.25%
20,767
– –
DISH
71
DELISTED
DISH Network Corp.
DISH
$583K 0.25%
10,200
– –
FISV
72
Fiserv Inc
FISV
$28.3B
$558K 0.24%
12,200
– –
ORCL icon
73
Oracle
ORCL
$435B
$532K 0.23%
14,555
– –
BMY icon
74
Bristol-Myers Squibb
BMY
$136B
$488K 0.21%
7,097
– –
COR icon
75
Cencora
COR
$61.5B
$460K 0.2%
4,436
– –
1 2
3
4 5

Similar funds

SC
Shellback Capital Boston, Massachusetts $1.14B AUM 49.89% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $1.14B AUM 79.59% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
RIM
RW Investment Management Eagle, Idaho $1.14B AUM
VCP
Vista Capital Partners Portland, Oregon $1.14B AUM 21.34% 1-Year Est. Return
HGIM
High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return
CAM
Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return
SIM
Symetra Investment Management Farmington, Connecticut $1.14B AUM 10.76% 1-Year Est. Return

Private Capital Advisors's Q4 2015 Portfolio in Review

As of Q4 2015, Private Capital Advisors held 116 positions worth $232M, down 3.1% from $239M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Private Capital Advisors withdrew a net $16.7M in Q4 2015, closing 9 positions and reducing 34 holdings. Its most notable exit was MacroGenics, an estimated $1.32M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 29% a quarter earlier, followed by Communication Services and Energy.

Against the trend, Private Capital Advisors opened a new position in Tvardi Therapeutics worth $4.16M.

  • Private Capital Advisors's largest Q4 2015 buy was Tvardi Therapeutics: 6,857 shares worth $4.16M.
  • Private Capital Advisors added most to Rocket Pharmaceuticals in Q4 2015, an estimated $523K increase.
  • Private Capital Advisors's biggest Q4 2015 reduction was Applied Genetic Technologies Corporation, cutting an estimated $4.54M.
  • Private Capital Advisors fully exited MacroGenics in Q4 2015, selling an estimated $1.32M.
  • Private Capital Advisors's ten largest holdings make up 29% of its $232M portfolio in Q4 2015.
  • Private Capital Advisors opened 2 new positions and closed 9 in Q4 2015.
  • Private Capital Advisors's portfolio value fell 3.1% quarter-over-quarter to $232M.

Based on Private Capital Advisors's 13F filing for Q4 2015, filed 22 Jan 2016.